Data from A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer
Published in 2023 by
Susana Banerjee 
,
Vasiliki Michalarea,
Joo Ern Ang,
Alvaro Ingles Garces,
Andrea Biondo,
Ionut-Gabriel Funingana,
Martin Little,
Ruth Ruddle,
Florence Raynaud ,
Ruth Riisnaes ,
Bora Gurel,
Sue Chua,
Nina Tunariu,
Joanna C. Porter,
Toby Prout
and other authors.
,
Vasiliki Michalarea,
Joo Ern Ang,
Alvaro Ingles Garces,
Andrea Biondo,
Ionut-Gabriel Funingana,
Martin Little,
Ruth Ruddle,
Florence Raynaud ,
Ruth Riisnaes ,
Bora Gurel,
Sue Chua,
Nina Tunariu,
Joanna C. Porter,
Toby Prout
and other authors.
